Long-term use safety Traditional pain meds: Not safe for years of continuous use Require breaks or rotation Accumulating damage to organs Peptides: Can use for months to years safely BPC-157 and TB-500 have decades of use data No cumulative toxicity Actually heal tissue rather than damage it Combining peptides with pain medications Can use together: Peptides for healing NSAIDs for acute breakthrough pain Reduce medication dose as peptides work Transition plan: Start peptides while on pain meds As pain improves, reduce medication slowly Goal: Minimal or no pain meds long-term See our peptide safety and risks guide
Muscle Injury and Repair BPC-157 exhibits potent muscle-protective and regenerative properties across various injury models
In vivo copper mediated free radical production: an ESR spin-trapping study
TB-500 Injections: Injectable TB-500 provides direct and efficient delivery into the body, allowing for quick absorption and potentially more potent effects compared to nasal administration
Patients should be monitored for serious adverse events including pancreatitis (severe abdominal pain radiating to the back, with or without vomiting), gallbladder disease, acute kidney injury (particularly with dehydration from persistent GI symptoms), diabetic retinopathy complications (with Ozempic/Rybelsus), and hypoglycemia (especially when used with insulin or sulfonylureas)
Body composition monitoring